Navigation Links
Video: Kyphon Supports World Osteoporosis Day on October 20, 2007 to Raise Awareness of Osteoporosis and Spinal Fracture Risk
Date:10/17/2007

ime at the Events Center at St. Mary's Cathedral, 1111 Gough St., San Francisco. The fair is sponsored by American Bone Health, in partnership with FORE and the University of California, San Francisco. In addition to the free bone density scanning, Kyphon representatives will be at the fair offering height measurement because loss of height can be an early indication of spinal fractures caused by osteoporosis. For more information about the event, contact FORE at 888-266-3015.

Kyphon is also supporting local and national awareness campaigns of osteoporosis organizations around the globe such as the Irish Osteoporosis Society (IOS), the Fundacion Hispana de Osteoporosis y Enfermedades Metabolicas (FHOEMO) of Spain, and the Italian Association for Patients with Osteoporosis (AECOS). In addition, Kyphon is offering free osteoporosis patient education posters for physicians' offices in countries across Europe.

Osteoporosis, a term that means "porous bones," is a disease in which bones become weak and can easily break. It is known as "the silent disease" because many of the estimated 75 million women and men in the United States, Europe and Japan who suffer from osteoporosis do not know they are losing bone mass until they experience a spine, hip or wrist fracture. Of the 1.5 million fractures attributable to osteoporosis that occur annually in the U.S., nearly half are spinal fractures, according to the National Osteoporosis Foundation. Kyphon markets medical devices that are used in minimally invasive therapies for the treatment of spinal fractures in order to improve the quality of life of those affected by spinal fractures caused by osteoporosis and cancer.

About Kyphon Inc.

Kyphon develops and markets medical devices designed to restore and preserve spinal function and diagnose the source of low back pain using minimally invasive technologies. The company's products are used in balloon kyphoplasty for the treatment of spinal compression fract
'/>"/>

SOURCE Kyphon Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Vitamin E supports Female Hearts
2. Injection supports Heart Devices
3. Study supports vegetable diet
4. Study supports century-old cancer theory
5. Google Supports Indians Novel Literacy Drive
6. Actor Anil Kapoor Supports Birth Registration Cause
7. AMA Supports Tax Penalty for Uninsured Americans
8. Church Supports HIV Test Before Marriage
9. EHRVA Supports EHR Product Certification
10. NICE supports application of advanced biological therapies as treatment option for acute psoriasis
11. Bush Supports Restriction to ‘Morning–After’ Pll
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)WASHINGTON, Dec. 5 ,, What: Cuts for a Cause ,, Why: To make a difference in the fight against cancer and other terminal illnesses affecting children. All proceeds from each hair service given
(Date:12/5/2009)Research debunks the ,something,s wrong with being single, myth , , SATURDAY, Dec. 5 (HealthDay News) -- Pity the poor single people who pass their 40th birthday without ever tying the knot, s
(Date:12/4/2009)PALO ALTO, Calif., Dec. 4 Varian Medical Systems (NYSE: VAR ) announced today that its Board of Directors has set the regular 2010 Annual Meeting of Stockholders for February 11, 2010 with a record
(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i
(Date:12/4/2009)WASHINGTON, Dec. 4 While Congress debates whether health care reform would control health care costs, Leapfrog,s purchaser members point to 45 hospitals that lead through example -- delivering the be
Breaking Medicine News(10 mins):Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3
..., April 24 Prime Therapeutics (Prime), a,thought ...oday that,Rachelle Wan, RPh, has joined the organi...ns., As Vice President of Pharmacy Trade Relation...rategic pharmacy,contracts and the performance of ...
...April 24 Life Brokerage Partners,announces three ...ms with,Peach Holdings, Inc. ("Peachtree"), Polari...premium finance programs are particularly valuable... and UNF,do not end with the agents, but extend to...
... Reveals Americans Are in Overdrive, Trend Exper...s Expert Denise Austin Offers Nightl...fter a long day at the,office, do you reach for yo...er than ever before, often at the expense of,their...
..., N.J., April 24 Cambrex,Corporation (NYSE: CBM ...8,financial results on Thursday, May 1, 2008 after...i-bin/prnh/20000613/CAMBREXLOGO ), The Company w... Thursday, May 1, 2008 at 5:00 p.m. Easter...
...homa Society and Ralph Lauren Center for Cancer Ca...Be Certified, NEW YORK, April 24 The Harold P. F...d that representatives from the Leukemia,& Lymphom...nic were the first to be trained in patient naviga...
...l 23 Young Innovations, Inc.,(Nasdaq: YDNT ) tod...1,2008., Sales for the first quarter of 2008 were...% from the $22.9 million reported in the first qua...come,was essentially unchanged at $2.8 million, co...
Other Medicine News:Health News:Life Brokerage Partners Strengthens Premium Finance Programs 2Health News:Wired, Working Americans Let Nighttime Health Routines Slide 2Health News:Wired, Working Americans Let Nighttime Health Routines Slide 3Health News:Wired, Working Americans Let Nighttime Health Routines Slide 4Health News:Harold P. Freeman Patient Navigation Institute Completes First Trainings and Certifications 2Health News:Harold P. Freeman Patient Navigation Institute Completes First Trainings and Certifications 3Health News:Harold P. Freeman Patient Navigation Institute Completes First Trainings and Certifications 4Health News:Harold P. Freeman Patient Navigation Institute Completes First Trainings and Certifications 5Health News:Harold P. Freeman Patient Navigation Institute Completes First Trainings and Certifications 6Health News:Young Innovations, Inc. Announces Results for the Quarter Ended March 31, 2008 2Health News:Young Innovations, Inc. Announces Results for the Quarter Ended March 31, 2008 3Health News:Young Innovations, Inc. Announces Results for the Quarter Ended March 31, 2008 4Health News:Young Innovations, Inc. Announces Results for the Quarter Ended March 31, 2008 5
(Date:12/4/2009)EMERYVILLE, Calif., Dec. 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that it will host an investor teleconference and webcast. Principal investigators will discuss the data present
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today the presentation of new d
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company is prese
Breaking Medicine Technology:Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6William Dwyer Named to PerfectServe Advisory Board 57496 1William Dwyer Named to PerfectServe Advisory Board 57496 2Photos 3A The Makers of LISTERINE 28R 29 and REACH 28R 29 TOTAL CARE Products Unveil a New Laugh Out Loud Book Benefiting the National Childrens Oral 57494 1Photos 3A The Makers of LISTERINE 28R 29 and REACH 28R 29 TOTAL CARE Products Unveil a New Laugh Out Loud Book Benefiting the National Childrens Oral 57494 2Photos 3A The Makers of LISTERINE 28R 29 and REACH 28R 29 TOTAL CARE Products Unveil a New Laugh Out Loud Book Benefiting the National Childrens Oral 57494 3Cyberonics to Present at Maxim Group Growth Conference 57492 1Cyberonics to Present at Maxim Group Growth Conference 57492 2
... Reported Safety & Tolerability Profile,in Sub...CHICAGO, June 25 /PRNewswire-FirstCall/ -- Phase I...of the American Diabetes,Association demonstrated ...dase-4 (DPP-4) in development by Bristol-Myers,Squ...), in,combination with metformin, exhibited a stat...
...-Funded Immune Globulin Study Uncovers Sample,Mani...PRNewswire-USNewswire/ -- An analysis,released tod...,study ruling out a link between autism and Rh imm...ained the mercury-based,preservative thimerosal. B...red manipulation of the study sample, so that,earl...
Other Medicine Technology:Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 2Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 3Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 4Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 5Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 6Genetics Journal Thimerosal/Autism Study the 'Best Science Drug,Company Money Can Buy' 2Genetics Journal Thimerosal/Autism Study the 'Best Science Drug,Company Money Can Buy' 3
QuikCoag CaCl2
QuikCoag Control 2
..., compact design. Using optical light scatter for ...YN 3200 meets the needs of today's laboratory. The...-part differential analysis, automated sample hand...y. The system combines proven Multi-Angle Polarize...
Perclose A-T Suture-Mediated Closure
Medicine Products: